The Role of Artificial Intelligence in Modern Drug Discovery and Development
DOI:
https://doi.org/10.22270/ajprd.v13i2.1544Abstract
Drug research and discovery have been completely transformed by artificial intelligence (AI), which has improved the precision and efficiency of crucial procedures. Conventional medication development is frequently risky, expensive, and slow. From target discovery to clinical trial design, artificial intelligence (AI) can speed up several phases of drug development with machine learning (ML) and deep learning (DL) algorithms. Early on, the identification of new therapeutic targets is made possible by AI models' ability to forecast possible drug-target interactions. Additionally, by evaluating enormous chemical databases to determine which molecules are most likely to display the necessary biological activity, AI optimizes lead discovery by facilitating high-throughput screening of compounds.
AI is also essential for drug repurposing, which is the process of finding new therapeutic uses for already-approved medications. AI can improve safety profiles by identifying trends in patient data that can be used to forecast unfavorable drug interactions. Furthermore, more precise in silico modeling is made possible by AI-driven simulations, which eliminates the need for expensive and time-consuming laboratory testing.
AI-enabled clinical trials further improve result prediction, patient monitoring, and patient selection. AI can predict efficacy, find appropriate trial candidates, and expedite trial design by examining genomic data and electronic health information.
The article explores how artificial intelligence (AI) is revolutionizing the entire drug development process, stressing both its present uses and its potential to change the pharmaceutical sector in the future and eventually result in the quicker and more affordable creation of new treatments.
Downloads
References
Zhavoronkov, A. Artificial Intelligence for the Development of Novel Chemistry, Biomarker Development, and Drug Discovery. Molecular Pharmaceutics, 2018;15(10): 4311–4313.
Clark, D., Czodrowski, P., Vanathevan, J., et al.. Machine learning applications in medication development and discovery. Nature Reviews Drug Discovery 2019; 18(6):463–477;
Zorn, K. M., Ekins, S., Puhl, A. C., et al. Utilizing machine learning to find and develop drugs from start to finish, Nature Materials, 2019; 18(5): 435–441.
Swanson, K., Yang, K., Stokes, J. M., et al. A Deep Learning Method for Finding Antibiotics. 2020; 180(4):688–702.e13; Cell.
Chen, H., Olivecrona, M., Engkvist, O., Wang, Y., & Blaschke, T. Deep learning's ascent in drug discovery. in Drug Discovery Today, 2018; 23(6): 1241–1250
Gawehn, E., Schneider, G., & Hiss, J. A. Drug discovery using deep learning. 2016; 35(1):3–14; Molecular Informatics.
Preuss, M., Waller, M. P., & Segler, M. H. S. (2018). Using symbolic AI and deep neural networks to plan chemical syntheses. in Nature, 2018; 555(7698): 604–610.
Grisoni, F., Schneider, G., & Jimenez-Luna, J. Explainable artificial intelligence in drug discovery. in Nature Machine Intelligence, 2020; 2(10): 573–584.
Shenoy, S., Paul, D., Sanap, G., et al. Artificial intelligence in the development of new drugs. in Drug Discovery Today, 2021; 26(1): 80–93.
Mak, K. K., and Pichika, M. R. Drug discovery using artificial intelligence: current state and potential future developments. Today, Drug Discovery, 2019; 24(3):773–780.
Chan, H. C. S., Shan, H., Vogel, H., Dahoun, T., & Yuan, S. Using artificial intelligence to advance drug discovery. 2019; 40(8):592–604; Trends in Pharmacological Sciences.
Mamoshina, P., Putin, E., Zivoronkov, A., & Vieira, A. Deep learning applications in biomedicine. in Molecular Pharmaceutics, 2016; 13(5): 1445–1454.
Atas, H., Martin, M. J., Rifaioglu, A. S., et al. Current techniques, resources, and databases for in silico drug discovery using deep learning and machine intelligence. Bioinformatics Briefings, 2019; 20(5), 1878-1912.
Zhang, L., Tan, J., Han, D., and Zhu, H. Advances in artificial intelligence for logical drug discovery: from machine learning to deep learning. in Drug Discovery Today, 2017; 22(11):1680–1685.
Goh, G. B., Vishnu, A., & Hodas, N. O. For computational chemistry, deep learning. in Journal of Computational Chemistry, 2017; 38(16):1291–1307.
Lacchia. Drug discovery using deep learning: potential, obstacles, and opportunities. Drug Discovery Today, (2019); 24(10):2017–2032.
A. Mullard. Pharmaceutical companies are interested in AI-powered medication discovery. in Nature Reviews Drug Discovery, (2021); 20(10): 725–727.
Murcko, M., Walters, W. P., & Murcko, M. A.. Evaluating how pharmaceutical chemistry is affected by generative AI. in Nature Biotechnology, (2020);38(2):143–145.
Schneider, G. Drug discovery automation. in Nature Reviews Drug Discovery, 2018; 17(2): 97–113.
Clark, D., Czodrowski, P., Vanathevan, J., et al. Machine learning applications in medication development and discovery. Nature Reviews Drug Discovery (2019); 18(6): 463–477.
Zorn, K. M., Ekins, S., Puhl, A. C., et al. Utilizing machine learning to find and develop drugs from start to finish, Nature Materials, (2019); 18(5):435–441.
Swanson, K., Yang, K., Stokes, J. M., et al. A Deep Learning Method for Finding Antibiotics. (2020); 180(4):688–702.e13; Cell.
Chen, H., Olivecrona, M., Engkvist, O., Wang, Y., & Blaschke, T. Deep learning's ascent in drug discovery. 1241–1250 in Drug Discovery Today, (2018); 23(6).
Schneider, G., Hiss, J. A., and Gawehn, E. Drug discovery using deep learning. (2016); 35(1):3–14; Molecular Informatics.
Waller, M. P., Segler, M. H. S., and Preuss, M.. Using symbolic AI and deep neural networks to plan chemical syntheses. in Nature, (2018); 604–610:555(7698).
Opera, T. I., and Hasselgren, C. Are We Nearing the End of Artificial Intelligence in Drug Discovery? Toxicology and Pharmacology Annual Review, 2023; 64:1–20.
Abbas and associates AI's function in drug discovery. E202300816 in ChemBioChem, 2024; 25(5).
V. D. Mouchlis et al. De Novo Drug Design Advances: Moving from Traditional to Machine Learning Approaches. Molecular Sciences International, 2021; 22(4):1676.
J. Vamathevan and colleagues. Machine learning applications in drug development and discovery. in Nature Reviews Drug Discovery, (2019);18(6): 463–477.
S. Ekins and colleagues. Using Machine Learning for Complete Drug Development and Discovery. Nature Materials, (2019);18(5):435–441.
Stokes and colleagues. A Deep Learning Method for Finding Antibiotics. (2020);180(4):688-702.e13; Cell.
Chen and colleagues. Deep learning's ascent in drug discovery. in Drug Discovery Today (2018); 23(6):1241–1250.
E. Gawehn and colleagues. Drug discovery using deep learning. (2016);35(1):3–14; Molecular Informatics.
M. H. S. Segler and associates. Using Symbolic AI and Deep Neural Networks to Plan Chemical Syntheses. in Nature, 555(7698).
2018); 604-610.
J. Jimenez-Luna and associates. Explainable Artificial Intelligence in Drug Discovery. in Nature Machine Intelligence (2020);573-584:2(10).
Published
How to Cite
Issue
Section
Copyright (c) 2025 Veeresh Kumar Rathour, Chitransh Saxena, Mukul Kumar, Hemant Brijay
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 